FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Clifford Shults

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Autoradiography

Co-author Network

Publications

TOP 3
Axel Lipp; Paola Sandroni; J Eric Ahlskog; Robert D Fealey; Kurt Kimpinski; Valeria Iodice; Tonette L Gehrking; Stephen D Weigand; David M Sletten; Jade A Gehrking; Kim K Nickander; Wolfgang Singer; Demetrius M Maraganore; Sid Gilman; Gregor K Wenning; Clifford W Shults; Phillip A Low
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.
Bernhard H Meurers; Gustavo Dziewczapolski; Tao Shi; Anton Bittner; Fredrik Kamme; Clifford W Shults
Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons.
Bernhard H Meurers; Gustavo Dziewczapolski; Anton Bittner; Tao Shi; Fredrik Kamme; Clifford W Shults
Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Clifford Shults (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Axel Lipp; Paola Sandroni; J Eric Ahlskog; Robert D Fealey; Kurt Kimpinski; Valeria Iodice; Tonette L Gehrking; Stephen D Weigand; David M Sletten; Jade A Gehrking; Kim K Nickander; Wolfgang Singer; Demetrius M Maraganore; Sid Gilman; Gregor K Wenning; Clifford W Shults; Phillip A Low
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.
Archives of neurology 2009;66(6):742-50.
2009: Bernhard H Meurers; Gustavo Dziewczapolski; Tao Shi; Anton Bittner; Fredrik Kamme; Clifford W Shults
Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(21):6828-39.
2009: Bernhard H Meurers; Gustavo Dziewczapolski; Anton Bittner; Tao Shi; Fredrik Kamme; Clifford W Shults
Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons.
Neurobiology of disease 2009;34(1):178-88.
2008: Nathan Pankratz; Karen Marder; Cheryl A Halter; Alice Rudolph; Clifford W Shults; William C Nichols; Tatiana Foroud
Clinical correlates of depressive symptoms in familial Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2216-23.
2008: Kiren Ubhi; Edward Rockenstein; Michael Mante; Christina Patrick; Anthony Adame; Monica Thukral; Clifford W Shults; Eliezer Masliah
Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy.
Neuroreport 2008;19(13):1271-6.
2007: Susanne May; Sid Gilman; B Brooke Sowell; Ronald Thomas; Matthew B Stern; Amy Colcher; Caroline M Tanner; Neng Huang; Peter Novak; Stephen G Reich; Joseph Jankovic; William G Ondo; Phillip A Low; Paola Sandroni; Axel Lipp; Frederick John Marshall; Frederick Wooten; Clifford W Shults
Potential outcome measures and trial design issues for multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2371-7.
2007: William C Nichols; Veronika E Elsaesser; Nathan Pankratz; Michael W Pauciulo; Diane K Marek; Cheryl A Halter; Alice Rudolph; Clifford W Shults; Tatiana Foroud
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
Neurology 2007;69(18):1737-44.
2007: A Lipp; Paola Sandroni; J Eric Ahlskog; Demetrius M Maraganore; Clifford W Shults; Phillip A Low
Calf venous compliance in multiple system atrophy.
American journal of physiology. Heart and circulatory physiology 2007;293(1):H260-5.
2007: Laurie J Ozelius; Tatiana Foroud; Susanne May; Geetha Senthil; Paola Sandroni; Phillip A Low; Stephen G Reich; Amy Colcher; Matthew B Stern; William G Ondo; Joseph Jankovic; Neng Huang; Caroline M Tanner; Peter Novak; Sid Gilman; Frederick John Marshall; G Frederick Wooten; Thomas C Chelimsky; Clifford W Shults
G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(4):546-9.
2007: William C Nichols; Diane K Marek; Michael W Pauciulo; Nathan Pankratz; Cheryl A Halter; Alice Rudolph; Clifford W Shults; Joanne Wojcieszek; Tatiana Foroud
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):254-7.
2006: Nathan Pankratz; Michael W Pauciulo; Veronika E Elsaesser; Diane K Marek; Cheryl A Halter; Alice Rudolph; Clifford W Shults; Tatiana Foroud; William C Nichols
Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2257-60.
2006: Nathan Pankratz; Michael W Pauciulo; Veronika E Elsaesser; Diane K Marek; Cheryl A Halter; Joanne Wojcieszek; Alice Rudolph; Clifford W Shults; Tatiana Foroud; William C Nichols
Mutations in DJ-1 are rare in familial Parkinson disease.
Neuroscience letters 2006;408(3):209-13.
2006: Clifford W Shults; Jennifer M Barrett; Deborah Fontaine
alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.
Neuroscience letters 2006;405(3):223-5.
2006: Clifford W Shults
Lewy bodies.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(6):1661-8.
2006: Nathan Pankratz; Lisa Byder; Cheryl A Halter; Alice Rudolph; Clifford W Shults; P Michael Conneally; Tatiana Foroud; William C Nichols
Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):45-9.
2005: Sid Gilman; S J May; Clifford W Shults; Caroline M Tanner; Walter A Kukull; Virginia M-Y Lee; Eliezer Masliah; Phillip Low; Paola Sandroni; John Q Trojanowski; Laurie J Ozelius; Tatiana Foroud
The North American Multiple System Atrophy Study Group.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(12):1687-94.
2005: Clifford W Shults; Edward Rockenstein; Leslie Crews; Anthony Adame; Michael Mante; Gabriel Larrea; Makoto Hashimoto; David Song; Takeshi Iwatsubo; Kyoko Tsuboi; Eliezer Masliah
Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(46):10689-99.
2005: Clifford W Shults
Reexamination of the TEMPO Study.
Archives of neurology 2005;62(8):1320; author reply 1321.
2005: Clifford W Shults
Therapeutic role of coenzyme Q(10) in Parkinson's disease.
Pharmacology & therapeutics 2005;107(1):120-30.
2005: Kyoko Tsuboi; John J Grzesiak; Michael Bouvet; Makoto Hashimoto; Eliezer Masliah; Clifford W Shults
Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death.
Molecular and cellular neurosciences 2005;29(2):259-68.
2005: Clifford W Shults
Antioxidants as therapy for Parkinson's disease.
Antioxidants & redox signaling 2005;7(5-6):694-700.
2005: William C Nichols; Nathan Pankratz; Dena Hernandez; Coro Paisan-Ruiz; Shushant Jain; Cheryl A Halter; Veronika E Michaels; Terry Reed; Alice Rudolph; Clifford W Shults; Andrew Singleton; Tatiana Foroud
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
Lancet 2005;365(9457):410-2.
2005: B Ravina; David Eidelberg; J Eric Ahlskog; Roger L Albin; David J Brooks; M Carbon; Vijay Dhawan; A Feigin; Stanley Fahn; M Guttman; Katrina Gwinn-Hardy; Henry McFarland; Robert B Innis; R G Katz; Karl Kieburtz; Stephen J Kish; N Lange; J William Langston; Kenneth Marek; L Morin; C Moy; D Murphy; Wolfgang H Oertel; G Oliver; Yuko Y Palesch; W Powers; John P Seibyl; Kapil D Sethi; Clifford W Shults; P Sheehy; A Jon Stoessl; R Holloway
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2005: Clifford W Shults; Richard Haas
Clinical trials of coenzyme Q10 in neurological disorders.
BioFactors (Oxford, England) 2005;25(1-4):117-26.
2004: Gregor Wenning; François Tison; Klaus Seppi; Cristina Sampaio; Anja Diem; Farid Yekhlef; Imad Ghorayeb; Fabienne Ory; Monique Galitzky; Tommaso Scaravilli; Maria Bozi; Carlo Colosimo; Sid Gilman; Clifford W Shults; Niall Quinn; Olivier Rascol; Werner Poewe
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1391-402.
2004: Clifford W Shults
Mitochondrial dysfunction and possible treatments in Parkinson's disease--a review.
Mitochondrion 2004;4(5-6):641-8.
2004: Clifford W Shults; M Flint Beal; David Song; Deborah Fontaine
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
Experimental neurology 2004;188(2):491-4.
2004: Robert G Holloway; Ira Shoulson; Stanley Fahn; Karl Kieburtz; Anthony E Lang; Kenneth Marek; Michael McDermott; John P Seibyl; William J Weiner; Bruno Musch; Cornelia Kamp; Mickie Welsh; Aileen Shinaman; Rajesh Pahwa; Lynn Barclay; Jean P Hubble; Peter LeWitt; Janis Miyasaki; Oksana Suchowersky; Mark Stacy; David S Russell; Blair Ford; John P Hammerstad; David Riley; David Standaert; Frederick Wooten; Stewart A Factor; Joseph Jankovic; Farah Atassi; Roger Kurlan; Michel Panisset; Ali H Rajput; Robert Rodnitzky; Clifford W Shults; Giselle Petsinger; Cheryl Waters; Ronald F Pfeiffer; Kevin Biglan; Leona Borchert; Amy Montgomery; Laura Sutherland; Carolyn Weeks; Maryan DeAngelis; Elspeth Sime; Susan Wood; Carol Pantella; Mary Harrigan; Barbara Fussell; Sandra Dillon; Barbara Alexander-Brown; Pamela Rainey; Marsha Tennis; Elke Rost-Ruffner; Diane Brown; Sharon Evans; Debra Berry; Jean Hall; Theresa Shirley; Judith Dobson; Deborah Fontaine; Brenda Pfeiffer; Alicia Brocht; Susan Bennett; Susan Daigneault; Karen Hodgeman; Carolynn O'Connell; Tori Ross; Karen Richard; Arthur Watts
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Archives of neurology 2004;61(7):1044-53.
2004: William C Nichols; Sean K Uniacke; Nathan Pankratz; Terry Reed; David K Simon; Cheryl A Halter; Alice Rudolph; Clifford W Shults; P Michael Conneally; Tatiana Foroud
Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):649-55.
2004: Clifford W Shults; Richard Haas; David Oakes; Karl Kieburtz; Sandra Plumb; Ira Shoulson; M Flint Beal; Jorge L Juncos; John G Nutt
Measuring the effects of therapy in Parkinson disease.
JAMA : the journal of the American Medical Association 2004;291(20):2430-1; author reply 2431.
2004: Nathan Pankratz; Sean K Uniacke; Cheryl A Halter; Alice Rudolph; Clifford W Shults; P Michael Conneally; Tatiana Foroud; William C Nichols
Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel loci.
Neurology 2004;62(9):1616-8.
2004: David D Song; Clifford W Shults; Abbyann Sisk; Edward Rockenstein; Eliezer Masliah
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.
Experimental neurology 2004;186(2):158-72.
2003: Clifford W Shults
Treatments of Parkinson disease: circa 2003.
Archives of neurology 2003;60(12):1680-4.
2003: David J Brooks; Kirk A Frey; Kenneth Marek; David Oakes; D Paty; R Prentice; Clifford W Shults; A Jon Stoessl
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental neurology 2003;184 Suppl 1():S68-79.
2003: Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl A Halter; Jill Murrell; Alice Rudolph; Clifford W Shults; P Michael Conneally; Tatiana Foroud
Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.
Human molecular genetics 2003;12(20):2599-608.
2003: G Dziewczapolski; D Chichung Lie; Jasodhara Ray; Fred H Gage; Clifford W Shults
Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats.
Experimental neurology 2003;183(2):653-64.
2003: Clifford W Shults
Coenzyme Q10 in neurodegenerative diseases.
Current medicinal chemistry 2003;10(19):1917-21.
2003: Irene Litvan; Kailash P Bhatia; David J Burn; Christopher G Goetz; Anthony E Lang; Ian G McKeith; Niall Quinn; Kapil D Sethi; Clifford W Shults; Gregor Wenning
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.
Movement disorders : official journal of the Movement Disorder Society 2003;18(5):467-86.
2003: Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl A Halter; Alice Rudolph; Clifford W Shults; P Michael Conneally; Tatiana Foroud
Significant linkage of Parkinson disease to chromosome 2q36-37.
American journal of human genetics 2003;72(4):1053-7.
2003: Tatiana Foroud; Sean K Uniacke; L Liu; Nathan Pankratz; Alice Rudolph; Cheryl A Halter; Clifford W Shults; Karen Marder; P Michael Conneally; William C Nichols
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease.
Neurology 2003;60(5):796-801.
2003: Eric Granholm; Shaunna K Morris; Douglas Galasko; Clifford W Shults; Erin Rogers; Boris Vukov
Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2003;47(2):95-115.
2003: M Flint Beal; Clifford W Shults
Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.
BioFactors (Oxford, England) 2003;18(1-4):153-61.
2002: Clifford W Shults; David Oakes; Karl Kieburtz; M Flint Beal; Richard Haas; Sandra Plumb; Jorge L Juncos; John G Nutt; Ira Shoulson; Julie H Carter; Katie Kompoliti; Joel S Perlmutter; Stephen G Reich; Matthew B Stern; Ray L Watts; Roger Kurlan; Eric S Molho; Madaline Harrison; Mark Lew
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Archives of neurology 2002;59(10):1541-50.
2002: D Chichung Lie; Gustavo Dziewczapolski; Andrew R Willhoite; Brian K Kaspar; Clifford W Shults; Fred H Gage
The adult substantia nigra contains progenitor cells with neurogenic potential.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(15):6639-49.
2002: Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl A Halter; Alice Rudolph; Clifford W Shults; P Michael Conneally; Tatiana Foroud
Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.
American journal of human genetics 2002;71(1):124-35.
2002: Edward Rockenstein; Margaret Mallory; Makoto Hashimoto; David Song; Clifford W Shults; Ingrid Lang; Eliezer Masliah
Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.
Journal of neuroscience research 2002;68(5):568-78.
2002: Gregory G Brown; Sandra J Brown; Gina Christenson; Rebecca E Williams; Sandra S Kindermann; Christopher Loftis; Ryan Olsen; Patricia Siple; Clifford W Shults; Jay M Gorell
Effects of task structure on category priming in patients with Parkinson's disease and in healthy individuals.
Journal of clinical and experimental neuropsychology 2002;24(3):356-69.
2002: Kyoko Tsuboi; Clifford W Shults
Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
Experimental neurology 2002;173(1):95-104.
2001: Clifford W Shults; Anthony H V Schapira
A cue to queue for CoQ?
Neurology 2001;57(3):375-6.
2000: Clifford W Shults; Jasodhara Ray; K Tsuboi; F H Gage
Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine.
Brain research 2000;883(2):192-204.
2000: Robert F Simons; B H Detenber; J E Reiss; Clifford W Shults
Image motion and context: a between- and within-subjects comparison.
Psychophysiology 2000;37(5):706-10.
2000: K Tsuboi; T A Kimber; Clifford W Shults
Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion.
Brain research 2000;866(1-2):55-64.
1999: Gregory G Brown; A A Rahill; Jay M Gorell; C McDonald; S J Brown; MC Sillanpaa; Clifford W Shults
Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.
Journal of geriatric psychiatry and neurology 1999;12(4):180-8.
1999: Clifford W Shults; Richard Haas; M Flint Beal
A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
BioFactors (Oxford, England) 1999;9(2-4):267-72.
1998: M J Roman; Dean C Delis; J Vincent Filoteo; TL Demadura; Jane S Paulsen; N R Swerdlow; M R Swenson; David P Salmon; N Butters; Clifford W Shults
Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task.
Journal of clinical and experimental neuropsychology 1998;20(6):873-84.
1998: Clifford W Shults; M Flint Beal; Deborah Fontaine; K Nakano; Richard Haas
Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients.
Neurology 1998;50(3):793-5.
1998: M Flint Beal; Russell T Matthews; A Tieleman; Clifford W Shults
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.
Brain research 1998;783(1):109-14.
1997: Clifford W Shults; Richard Haas; D Passov; M Flint Beal
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.
Annals of neurology 1997;42(2):261-4.
1997: J Vincent Filoteo; Dean C Delis; David P Salmon; TL Demadura; M J Roman; Clifford W Shults
An examination of the nature of attentional deficits in patients with Parkinson's disease: evidence from a spatial orienting task.
Journal of the International Neuropsychological Society : JINS 1997;3(4):337-47.
1996: Clifford W Shults; T Kimber; D Martin
Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine.
Neuroreport 1996;7(2):627-31.
1995: J Vincent Filoteo; Dean C Delis; M J Roman; TL Demadura; E Ford; N Butters; David P Salmon; Jane S Paulsen; Clifford W Shults; M Swenson
Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias.
Journal of clinical and experimental neuropsychology 1995;17(5):654-67.
1995: Richard Haas; F Nasirian; K Nakano; D Ward; M Pay; R Hill; Clifford W Shults
Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease.
Annals of neurology 1995;37(6):714-22.
1995: Clifford W Shults; T Kimber; C A Altar
BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine.
Neuroreport 1995;6(8):1109-12.
1995: C A Lucidi-Phillipi; Fred H Gage; Clifford W Shults; K R Jones; Louis F Reichardt; U J Kang
Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain.
The Journal of comparative neurology 1995;354(3):361-76.
1995: Clifford W Shults; F Nasirian; D M Ward; K Nakano; M Pay; L R Hill; Richard Haas
Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism.
Neurology 1995;45(2):344-8.
1995: T Saitoh; Y Xia; X Chen; Eliezer Masliah; Douglas Galasko; Clifford W Shults; Leon J Thal; Lawrence A Hansen; Robert Katzman
The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease.
Annals of neurology 1995;37(1):110-2.
1994: A M Gonzalez; L S Carman; M Ong; Jasodhara Ray; Fred H Gage; Clifford W Shults; Andrew Baird
Storage, metabolism, and processing of 125I-fibroblast growth factor-2 after intracerebral injection.
Brain research 1994;665(2):285-92.
1994: Clifford W Shults; Russell T Matthews; C A Altar; L R Hill; Philip J Langlais
A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats.
Experimental neurology 1994;125(2):183-94.
1993: Clifford W Shults; T A Kimber
Thy-1 immunoreactivity distinguishes patches/striosomes from matrix in the early postnatal striatum of the rat.
Brain research. Developmental brain research 1993;75(1):136-40.
1993: Clifford W Shults
Effect of selegiline (deprenyl) on the progression of disability in early Parkinson's disease. Parkinson Study Group.
Acta neurologica Scandinavica. Supplementum 1993;146():36-42.
1992: Clifford W Shults; L Alberti; T A Kimber; William B Stallcup
Mesostriatal dopaminergic axons transiently express high levels of NILE during development.
Experimental neurology 1992;116(3):275-85.
1992: Clifford W Shults
Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors.
Neurologic clinics 1992;10(2):567-93.
1992: Clifford W Shults; T A Kimber
Mesencephalic dopaminergic cells exhibit increased density of neural cell adhesion molecule and polysialic acid during development.
Brain research. Developmental brain research 1992;65(2):161-72.
1991: L S Carman; Fred H Gage; Clifford W Shults
Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior.
Brain research 1991;553(2):275-83.
1991: Clifford W Shults; Daniel O'Connor; Andrew Baird; R Hill; Christopher G Goetz; Ray L Watts; H L Klawans; Paul Carvey; Roy A E Bakay; F H Gage
Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid.
Experimental neurology 1991;111(3):276-81.
1990: Clifford W Shults; R Hashimoto; R M Brady; F H Gage
Dopaminergic cells align along radial glia in the developing mesencephalon of the rat.
Neuroscience 1990;38(2):427-36.
1989: William C Heindel; David P Salmon; Clifford W Shults; P A Walicke; N Butters
Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1989;9(2):582-7.
1988: Fred H Gage; J A Wolff; M B Rosenberg; L Xu; J K Yee; Clifford W Shults; Theodore Friedmann
Implantation of genetically engineered cells to the brain.
Progress in brain research 1988;78():651-8.
1987: Fred H Gage; J A Wolff; M B Rosenberg; L Xu; J K Yee; Clifford W Shults; Theodore Friedmann
Grafting genetically modified cells to the brain: possibilities for the future.
Neuroscience 1987;23(3):795-807.
1987: Clifford W Shults; P Johnston; F H Gage
Comparison of substance K-like and substance P-like fibers and cells in the rat hippocampus.
Brain research 1987;426(2):290-6.
1987: H S Bracha; Clifford W Shults; S D Glick; J E Kleinman
Spontaneous asymmetric circling behavior in hemi-parkinsonism; a human equivalent of the lesioned-circling rodent behavior.
Life sciences 1987;40(11):1127-30.
1987: G E Handelmann; Clifford W Shults; T L O'Donohue
A developmental influence of substance P on its receptors.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1987;5(1):11-5.
1986: S H Buck; C J Helke; E Burcher; Clifford W Shults; T L O'Donohue
Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system.
Peptides 1986;7(6):1109-20.
1986: Clifford W Shults; L Steardo; P Barone; E Mohr; Jorge L Juncos; C Serrati; P Fedio; Carol A Tamminga; Thomas N Chase
Huntington's disease: effect of cysteamine, a somatostatin-depleting agent.
Neurology 1986;36(8):1099-102.
1986: J T Simmons; B Pastakia; Thomas N Chase; Clifford W Shults
Magnetic resonance imaging in Huntington disease.
AJNR. American journal of neuroradiology 1986;7(1):25-8.
1985: V J Massari; Clifford W Shults; C H Park; Y Tizabi; T W Moody; B M Chronwall; M Culver; Thomas N Chase
Deafferentation causes a loss of presynaptic bombesin receptors and supersensitivity of substance P receptors in the dorsal horn of the cat spinal cord.
Brain research 1985;343(2):268-74.
1985: Clifford W Shults; H Yajima; H G Gullner; Thomas N Chase; T L O'Donohue
Demonstration and distribution of kassinin-like material (substance K) in the rat central nervous system.
Journal of neurochemistry 1985;45(2):552-8.
1985: Clifford W Shults; S H Buck; E Burcher; Thomas N Chase; T L O'Donohue
Distinct binding sites for substance P and neurokinin A (substance K): co-transmitters in rat brain.
Peptides 1985;6(2):343-5.
1985: R P Newman; Peter LeWitt; Clifford W Shults; G Bruno; N L Foster; Thomas N Chase; Donald B Calne
Dystonia: treatment with bromocriptine.
Clinical neuropharmacology 1985;8(4):328-33.
1984: T L O'Donohue; V J Massari; Chistopher Pazoles; B M Chronwall; Clifford W Shults; R Quirion; Thomas N Chase; T W Moody
A role for bombesin in sensory processing in the spinal cord.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1984;4(12):2956-62.
1984: S H Buck; E Burcher; Clifford W Shults; W Lovenberg; T L O'Donohue
Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor.
Science (New York, N.Y.) 1984;226(4677):987-9.
1984: Clifford W Shults; R Quirion; B Chronwall; Thomas N Chase; T L O'Donohue
A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system.
Peptides 1984;5(6):1097-128.
1984: E Burcher; Clifford W Shults; S H Buck; Thomas N Chase; T L O'Donohue
Autoradiographic distribution of substance K binding sites in rat gastrointestinal tract: a comparison with substance P.
European journal of pharmacology 1984;102(3-4):561-2.
1984: C H Park; V J Massari; R Quirion; Y Tizabi; Clifford W Shults; T L O'Donohue
Characteristics of 3H-substance P binding sites in rat brain membranes.
Peptides 1984;5(4):833-6.
1984: C J Helke; Clifford W Shults; Thomas N Chase; T L O'Donohue
Autoradiographic localization of substance P receptors in rat medulla: effect of vagotomy and nodose ganglionectomy.
Neuroscience 1984;12(1):215-23.
1984: J R Keeler; Clifford W Shults; Thomas N Chase; C J Helke
The ventral surface of the medulla in the rat: pharmacologic and autoradiographic localization of GABA-induced cardiovascular effects.
Brain research 1984;297(2):217-24.
1983: S S Wolf; T W Moody; R Quirion; Clifford W Shults; Thomas N Chase; T L O'Donohue
Autoradiographic visualization of substance P receptors in rat brain.
European journal of pharmacology 1983;91(1):157-8.
1983: R Quirion; Clifford W Shults; T W Moody; C B Pert; Thomas N Chase; T L O'Donohue
Autoradiographic distribution of substance P receptors in rat central nervous system.
Nature 1983;303(5919):714-6.
1982: Clifford W Shults; R Quirion; R T Jensen; T W Moody; T L O'Donohue; Thomas N Chase
Autoradiographic localization of substance P receptors using 125I substance P.
Peptides 1982;3(6):1073-5.
1978: Clifford W Shults; J N Whitaker; J G Wood
Myelin basic protein microheterogeneity in subfractions of rat brain myelin.
Journal of neurochemistry 1978;30(6):1543-51.